PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33833403-13	2022	We observe higher MMP9 plasma levels in SCZ, associated with lower hippocampal volumes, suggesting involvement of MMP9 in the pathology of SCZ.	SCZ	40-43	matrix metallopeptidase 9	Homo sapiens	18-22	
33833403-13	2022	We observe higher MMP9 plasma levels in SCZ, associated with lower hippocampal volumes, suggesting involvement of MMP9 in the pathology of SCZ.	SCZ	40-43	matrix metallopeptidase 9	Homo sapiens	114-118	
33833403-13	2022	We observe higher MMP9 plasma levels in SCZ, associated with lower hippocampal volumes, suggesting involvement of MMP9 in the pathology of SCZ.	SCZ	139-142	matrix metallopeptidase 9	Homo sapiens	18-22	
33833403-13	2022	We observe higher MMP9 plasma levels in SCZ, associated with lower hippocampal volumes, suggesting involvement of MMP9 in the pathology of SCZ.	SCZ	139-142	matrix metallopeptidase 9	Homo sapiens	114-118	
33833403-14	2022	Future studies are needed to investigate how MMP9 influences the pathology of SCZ over the lifespan, whether the observed associations are specific for schizophrenia, and if a therapeutic modulation of MMP9 promotes neuroprotective effects in SCZ.	SCZ	243-246	matrix metallopeptidase 9	Homo sapiens	202-206